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Background
•  Changes to reimbursement models have shifted 
how health systems provide patient care
•  Commercial payors are driving health care 
services to lower cost sites of care (i.e. non-
hospital based infusion centers), including 
services such as medication administration.
•  To ensure medication administration occurs 
within the most cost-effective setting, a list of 
restricted medications was developed at Lehigh 
Valley Health Network.
   Medications were included if high-cost, used 
for management of chronic disease states, or 
targeted for outpatient administration
   Three-step approval process (provider contact, 
pharmacy administrator approval, pharmacist 
documentation)
   List has not been formally reviewed or revised  
since 2017
•  Goal of this quality improvement project was to 
assess the inpatient use of restricted 
medications and identify changes that should be 
made or opportunities for education to 
streamline the approval process while mitigating 
effects of changing sites of care and 
reimbursement.
Methods
•  Retrospective review of electronic medical 
records of inpatient administrations of restricted 
medications between July 1, 2018 and June 30, 
2020 at LVH–Cedar Crest and LVH–Muhlenberg.
•  Evaluations performed:
   Calculated total number of doses administered 
per medication per fiscal year (July 1–June 30)
   Stratified usage by drug and patient location 
and identified significant trends in prescribing
   Quantified documentation for usage approval 
and assessed for consistency
Results









Bendamustine 7 (12.5) 7 (13.7)
Leuprolide 13 (23.2) 4 (7.8)
Tocilizumab 12 (21.4) 1 (2.0)
Vedolizumab 8 (14.3) 14 (27.5)
Patient-supplied medication 7 (12.5) 8 (15.7)
Rationale for inpatient administration
Administration logistics 50 (89.3) 29 (56.9)
Medically necessary 16 (28.6)^ 35 (68.6)^
*Administrations by hospital campus (2018-2019: Cedar Crest n=54, Muhlenberg n=2; 
2019-2020: Cedar Crest n=39, Muhlenberg n=12)
^Medically necessary doses (2018-2019: 14 initial doses; 2 maintenance doses;  
2019-2020: 32 initial doses; 3 maintenance doses)
■ Pediatrics    ■ Oncology    ■ Med/Surg    ■ ICU
Conclusions
•  Administration of patient’s own medications was 
faciliated across fiscal years
•  More restricted medications ordered by oncology 
department and administered for medical 
treatment of acute conditions in 2019-2020 vs 
2018-2019
•  Failure to document intervention or 
communication with providers regarding 
restricted medication administration occurred 
more than 1/3 of the time
   Documentation disparity varied by hospital 
campus
Restricted Medication Administration by Hospital Service 
Figure 1: 2018–2019 Figure 2: 2019–2020
Documentation for Restricted Medication Use
Figure 3: 2018–2019 Figure 4: 2019–2020
■ Pediatrics    ■ Oncology    ■ Med/Surg    ■ ICU
■ Per Protocol    ■ No Documentation    ■ Pharmacist Intervention    
■ Contacted Provider   ■ Administrator Approval
■ Pharmacist Intervention ■ No Documentation        
■ Contacted Provider ■ Administrator Approval
